ACTR-33. A PHASE I DOSE ESCALATION AND CENTRAL NERVOUS SYSTEM (CNS) PHARMACOKINETIC STUDY OF PULSATILE AFATINIB IN PATIENTS WITH BRAIN CANCER

Patients with primary brain cancer or brain metastases represent a population with a large unmet medical need. The critical premise behind our investigation into pulse dosing of growth factor inhibitors for brain cancer is that current treatment is limited by drug penetration into the central nervou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Juarez, Tiffany, Boucher, Najee, Heng, Annie, Gill, Jaya, Nguyen, Minhdan, Truong, Judy, Saria, Marlon, Achrol, Achal, Barkhoudarian, Garni, Kelly, Daniel, Kesari, Santosh
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692747/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.026
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados